Immunotherapy Approaches in Cancer Treatment

Result code in IS VaVaI

<a href="https://www.isvavai.cz/riv?ss=detail&h=RIV%2F00216208%3A11110%2F15%3A10296029" target="_blank" >RIV/00216208:11110/15:10296029 - isvavai.cz</a>

Alternative codes found

RIV/00023736:_____/15:00011371 RIV/00064165:_____/15:10296029

Result on the web

<a href="http://dx.doi.org/10.2174/1389201016666150619114554" target="_blank" >http://dx.doi.org/10.2174/1389201016666150619114554</a>

DOI - Digital Object Identifier

<a href="http://dx.doi.org/10.2174/1389201016666150619114554" target="_blank" >10.2174/1389201016666150619114554</a>

Result language

angličtina

Original language name

Immunotherapy Approaches in Cancer Treatment

Original language description

Tumor immune surveillance paradigm presumes that most pre-malignant cells or early malignant lesions can be eliminated (or at least controlled) by cells of the immune system. A critical feature that distinguishes advanced tumors from early neoplastic lesions is their capability to evade immune control. As a consequence, vast majority of clinically evident (advanced) tumors are poorly immunogenic. The principle goal of immunotherapy is thus a resurrection of the patient's inefficient or suppressed immunesystem so that it would once again become capable of launching sustained cytolytic attacks against tumor cells, which would ideally result in total and permanent eradication of cancer. Such activation of patient's anticancer immunity, however, can be achieved by strikingly different ways. This current review discusses diverse innovative immunotherapy approaches, which in the last 20 years achieved miraculous successes in the ever-lasting battle against cancer, including cytokine-based i

Czech name

—

Czech description

—

Type

J_x - Unclassified - Peer-reviewed scientific article (Jimp, Jsc and Jost)

CEP classification

FD - Oncology and haematology

OECD FORD branch

—

Project

Result was created during the realization of more than one project. More information in the Projects tab.

Continuities

S - Specificky vyzkum na vysokych skolach<br>I - Institucionalni podpora na dlouhodoby koncepcni rozvoj vyzkumne organizace

Publication year

2015

Confidentiality

S - Úplné a pravdivé údaje o projektu nepodléhají ochraně podle zvláštních právních předpisů

Name of the periodical

Current Pharmaceutical Biotechnology

ISSN

1389-2010

e-ISSN

—

Volume of the periodical

16

Issue of the periodical within the volume

9

Country of publishing house

AE - UNITED ARAB EMIRATES

Number of pages

11

Pages from-to

771-781

UT code for WoS article

000358015000004

EID of the result in the Scopus database

—